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Abstract
Painful intervertebral disc disease is characterised not only 
by an imbalance between anabolic (i.e., matrix synthesis) 
and catabolic (i.e., matrix degradation) processes, but also 
by infl ammatory mechanisms. The increased expression 
and synthesis of matrix metalloproteinases and infl am-
matory factors is mediated by specifi c signal transduc-
tion, in particular the nuclear factor-kappaB (NF-B) 
and mitogen-activated protein kinase (MAPK)-mediated 
pathways. NF-B and MAPK have been identifi ed as the 
master regulators of infl ammation and catabolism in several 
musculoskeletal disorders (e.g., osteoarthritis), and recently 
growing evidence supports the importance of these signal-
ling pathways in painful disc disease. With continuing 
research exploiting in vitro and in vivo model systems to 
elucidate the roles of these pathways in disc degeneration, 
it may be possible in the near future to specifi cally target 
these major infl ammatory / catabolic signalling pathways 
to treat painful degenerative disc disease. In this perspec-
tive, we aim to summarise the current state of knowledge 
concerning the infl ammatory and catabolic molecular path-
ways of intervertebral disc disease (IDD), with a detailed 
description of NF-B and MAP kinase-mediated signal 
transduction in disc cells. Furthermore, we will discuss the 
emerging novel molecular treatment modalities for IDD 
using pharmacological inhibitors targeting these pathways.
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Abbreviations
ASIC           Acid-sensing ion channel
ASS           Acetylic salicylic acid
AF            Annulus fi brosus
COX            Cyclooxygenase
CPB           Creb-binding protein
EG-1           Early growth factor 1
EMSA           Electrophoretic mobility shift analysis
EP            Endplate
ERK           Extracellular signal-regulated kinase 
bFGF           Basic fi broblast growth factor
Gluc AT-1          -1,3-glucuronyl-transferase 1
IDD           Intervertebral disc disease
IGF-I           Insulin-like growth factor-I
IL             Interleukin
IκB           Inhibitor of κB
IKK           IκB kinase
iNOS           Inducible nitric oxide synthase
IVD           Intervertebral disc
JNK            Jun NH2-terminal kinase
LPS           Lipopolysaccharide
MAPK           Mitogen-activated protein kinase
MCP-1           Monocyte chemotactic protein-1
MKK            MAPK kinase
MMP            Matrix metalloproteinase
NBD           NEMO binding domain
NEMO           NF-B essential modulator
NF            Nuclear factor
NGF           Nerve growth factor
NO            Nitric oxide
NP            Nucleus pulposus
ODN           Naked decoy oligonucleotide
p75NTR            p75 neurotrophin receptor
PDGF           Platelet-derived growth factor
PGE           Prostaglandin E
PI3K           Phosphatidylinositol 3-kinase
PKC           Protein kinase C
RHD           Rel homology domain
TGF           Transforming growth factor
TIMP           Tissue inhibitor of metalloproteinases
TNF            Tumor necrosis factor
TonEBP           Tonicity-responsive enhancer binding protein
TSLP           Thymic stromal lymphopoietin
TWEAK           Tumor necrosis like weak inducer of apoptosis
VEGF           Vascular endothelial growth factor
Introduction
Degeneration of the intervertebral disc (IVD) is a normal 
part of the ageing process, and is typically characterised 
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by a loss of disc extracellular matrix. This loss is due to 
perturbed matrix homeostasis, whereby matrix anabolism 
is decreased and matrix catabolism is increased. Aging is 
associated with increased cellular senescence and changes 
in disc cellular phenotype that result in cells with decreased 
matrix synthesis capacity and/or altered matrix produc-
tion. Additionally, enzymes mediating matrix degrada-
tion, including matrix metalloproteinases (MMPs), are 
up-regulated during the process of IVD degeneration and 
aging, resulting in increased matrix degradation (Cui et 
al., 2010; Roberts et al., 2000; Weiler et al., 2002). Con-
sequently, loss and remodelling of the extracellular matrix 
(ECM) can lead to the occurrence of clefts and tears and 
eventually complete disc structural failure.
 Despite the large structural changes in their discs, 
patients with IVD degeneration often remain symptom-
free. Nevertheless, a subgroup of individuals with IVD 
degeneration experience pain and thus can be categorised 
to have intervertebral disc disease (IDD). A recent system-
atic review indicated that the odds of chronic low back 
pain given the presence of disc degeneration (detected by 
magnetic resonance imaging changes) ranged from 1.8 to 
2.8, meaning that the chances of suffering from back pain 
in people with degenerated discs was 2-3 times higher 
than in individuals without degenerated discs (Chou et al., 
2011). Important in the context of disc-related back pain 
is the observed phenomenon of innervation of sensory 
nerve fi bres in degenerated discs. These sensory nerves, 
containing nociception-related mediators such as substance 
P or calcitonin can penetrate not only into the peripheral 
annulus fi brosus (AF), but also into deeper zones of de-
generated discs, especially if radial fi ssures and reduced 
pressure in the nucleus pulposus are present, (Adams et 
al., 1996; Freemont et al., 1997; Hastreiter et al., 2001; 
Ozawa et al., 2006; Peng et al., 2006; Peng et al., 2005). 
Irritation of these sensory nerves has been described as 
a major underlying mechanism of discogenic back pain, 
which may occur via infl ammatory processes (Goupille 
et al., 2007; Olmarker and Rydevik, 1998). Recently, 
surgically-removed human degenerative discs were shown 
to be actively infl ammatory (Adams et al., 2010). Past 
research has also provided evidence that IDD is correlated 
to increased levels of pro-infl ammatory cytokines in disc 
tissue, such as interleukin 1β (IL-1β), interleukin 6 (IL-6), 
interleukin 8 (IL-8) and tumor necrosis factor α (TNF-α): 
LeMaitre et al. (2007) demonstrated that herniated discs 
and degenerated discs from patients with chronic back 
pain showed higher expression of IL-1β and TNF-α than 
non-degenerated discs derived from post-mortem tissue 
from people without a history of back pain. In fact, not 
only IL-1β, but also IL-1α, type-I receptor of IL-1 and the 
IL-1β-converting enzyme were present in higher levels in 
degenerated samples compared to non-degenerated ones 
(Le Maitre et al., 2005). Furthermore, TNF-α expression 
increased continuously with age in the AF and up to the 
age of 60 years in the nucleus pulposus (NP) in a popula-
tion study consisting of autopsy samples that did not have 
any medical notes concerning relevant back problems 
(Bachmeier et al., 2007). Importantly, surgical samples 
from patients with a low back pain history (protrusion, 
herniation, degenerative disc disease) showed higher level 
of TNF-α positively labelled cells than the autopsy group 
(Bachmeier et al., 2007). Similarly, Weiler et al. (2005) 
demonstrated that surgical disc tissue from symptomatic 
back pain patients contained more TNF-α positive cells 
than asymptomatic autopsy samples, with a positive cor-
relation to the degree of degeneration for the AF. Burke 
et al. (2002) clearly demonstrated that disc tissue from 
patients with discogenic back pain revealed higher protein 
levels of IL-6 and IL-8 than patients with sciatica. A most 
recent immunohistochemical comparison of surgical disc 
tissue (degenerative disc disease, disc herniation) and 
non-degenerated autopsy discs showed higher expres-
sion of IL-4, IL-6 and IL-12 in surgical samples than in 
autopsy samples, but with highest levels in the cases of 
disc herniation (Shamji et al., 2010). In summary, these 
studies indicate that the infl ammatory mediators play an 
important role in the processes of IDD and possibly IDD-
related back pain.
 During the past years, gene expression and function of 
these mediators in IDD have been a major topic of research 
interest. Furthermore, extensive therapeutic studies in the 
fi eld of osteoarthritis and rheumatoid arthritis have high-
lighted the need to identify the underlying signalling path-
ways, prompting scores of IVD researchers to explore the 
molecular mechanisms leading to IVD infl ammation and 
catabolism. This review describes two major intracellular 
pathways, nuclear factor kappa B (NF-B) and mitogen-
activated protein kinases (MAPKs), which potentially play 
vital roles in mediating the molecular events responsible 
for the initiation and progression of IDD. A graphical 
illustration of the NF-B and MAP kinase pathways (as 
described in this review paper) is given in Fig. 1. Although 
this review focuses primarily on the NF-B and MAPK 
pathways, the reader should keep in mind that the fi nal 
effect of the activation of signalling pathways depends on 
their “crosstalk” with other activated pathways. For in-
stance, a pathway that crosstalks with both the MAPK and 
the NF-B pathways is the phosphatidylinositol 3-kinase 
(PI3K)/Akt axis (Conejo et al., 2002; Koh et al., 2006), 
which also seems to be involved in IVD homeostasis, e.g. 
by regulating aggrecan expression, glycosaminoglycan 
deposition and cell survival (Cheng et al., 2009; Risbud 
et al., 2005b).
Transcription Factor NF-B
NF-κB is a central component in the cellular response 
to damage, stress and infl ammation. NF-κB was fi rst de-
scribed in 1986 in B-lymphocytes and acquired its name as 
it was found in the nucleus where it bound to an enhancer 
element of the immunoglobulin kappa light chain gene (Sen 
and Baltimore, 1986). NF-κB proteins comprise a family 
of structurally related “rapid-acting” transcription factors, 
all sharing a common highly conserved 300-amino acid 
region, the Rel homology domain (RHD). In mammals, 
the ubiquitously expressed NF-κB family consists of fi ve 
protein subunits, RelA or p65, c-Rel, RelB, p50 and p52. 
NF-κB exists either as a homodimer or a heterodimer, 
the most abundant being the p50-p65 heterodimer, which 
controls the expression of the majority of NF-κB-regulated 
genes (Baeuerle and Henkel, 1994).
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Fig. 1. MAPK and NF-B pathways. (A) Canonical cascades of the MAP kinases and NF-B signalling pathway 
(Hacker and Karin, 2006; Roux and Blenis, 2004). Left panel: Representative modules of the pathway connections 
for the respective MAPK phosphorelay systems. The complexity of the system is evident in the multiple stimuli lead-
ing to various biological responses through the multi-component levels of MAKKKs, MAKKs, and MAPKs. Right 
panel: Representative modules in the canonical NF-B signalling. Specifi c cross talks between the components of 
MAPK and NF-B pathways are included (red arrows). (B) Current reported literature of involvement of MAPK 
and NF-B pathways in intervertebral discs. Left panel: Involvement of the MAPK signalling in disc metabolism. 
Infl ammatory stress perturbs disc matrix homeostasis through the ERK, p38, and JNK-mediated pathways, while 
both ERK and p38 are reported to mediate stimuli from mechanical stress and growth factors on disc cell apoptosis 
and senescence. Elevated in degenerated discs, cellular senescence might be mediated by p38 in disc cells (dashed 
line) as activation of p38a is required for stress-induced cellular senescence in other cell types (Freund et al., 2010). 
Right panel: Involvement of the NF-B signalling in disc metabolism. Infl ammatory and mechanical stress are known 
to activate NF-B in disc cells, leading to expression of key catabolic factors such as MMPs. Elevation of NF-B 
is also reported in an accelerated aging mouse model due to DNA repair defi ciency as well as in the injury-induced 
IDD rabbit model, both of which correlate to disc matrix loss. In animal studies, blocking NF-B activity using the 
NF-B decoy ODN proved effective in partially restoring IVD height in a rabbit model of IDD induced by annular 
puncture (Akeda et al., 2005), or NBD (nemo binding domain) peptide which inhibits IKK formation ameliorates 
age-related disc matrix loss in the progeroid mouse model (Nasto et al., 2011). Consistent with these fi ndings are 
reports of increased NF-B activation and activity in aged and degenerated disc.
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 The transcription activity of NF-κB is tightly controlled 
by binding of inhibitor of NF-κB (IκB) proteins, resulting 
in sequestration of NF-κB in the cytoplasm. Depending on 
IκB modifi cation, the NF-κB/IκB complex can either be 
retained in the cytoplasm or can be a constantly shuttled 
between cytoplasm and nucleus, but with a balance that is 
largely shifted towards nuclear export rather than import 
(Web ref. 1). Canonical activation of NF-κB is mediated 
by IκB kinase (IKK), a heterotrimer consisting of two cata-
lytic subunits, IKK and IKKß, and a regulatory subunit 
termed IKKγ or NEMO (NF-κB essential modulator). In 
response to a variety of stimuli, including pro-infl ammatory 
cytokines, pathogens, cellular stress, mechanical stress, 
radiation, and growth factors, IKK becomes activated and 
phosphorylates IκB at two specifi c serine residues (S32 
and S36), leading to its ubiquitination and subsequent 
Table 1: Summary of target genes of NF-κB and MAPK in IVD cells.
Gene Signalling Pathway Species Reference Gene Function
ADAMTS4 NF-κB Human (Wang et al., 2012) Matrix degrading enzyme
ADAMTS5 NF-κB Human (Wang et al., 2012) Matrix degrading enzyme
Aggrecan p38
ERK
Rabbit
Bovine
Bovine
(Studer et al., 2008)
(Kim et al., 2012)
(Kim et al., 2012)
Matrix protein
ASIC3 ERK Rat (Uchiyama et al., 2007) Ion channel
Collagen I p38 Rabbit (Studer et al., 2008) Matrix protein
Collagen II ERK Human (Xia and Zhu, 2010) Matrix protein
COX-2 p38 Rabbit (Studer et al., 2008) Prostaglandin biosynthesis 
IGF-1 p38 Rabbit (Studer et al., 2008) Growth factor
IL-6 p38 Human
Rabbit
(Kim et al., 2009)
(Studer et al., 2008)
Cytokine
IL-8 p38 Human (Kim et al., 2009) Cytokine
iNOS p38
ERK
Bovine
Bovine
(Kim et al., 2012)
(Kim et al., 2012)
NO biosynthesis
MCP-1 NF-κB Mouse (Wako et al., 2008) Cytokine
MMP1 NF-κB
p38
JNK
Human
Bovine
Bovine 
(Pichika et al., 2005)
(Seguin et al., 2006)
(Seguin et al., 2006)
Matrix degrading enzyme
MMP2 NF-κB
ERK
Human 
Bovine
(Pichika et al., 2005)
(Seguin et al., 2008)
Matrix degrading enzyme
MMP3 NF-κB
p38
JNK
Human 
Bovine
Rabbit
Bovine
Mouse
(Pichika et al., 2005)
(Seguin et al., 2006)
(Studer et al., 2008)
(Seguin et al., 2006) 
(Wako et al., 2008)
Matrix degrading enzyme
MMP9 NF-κB
ERK
Human
Human 
(Pichika et al., 2005)
 (Xia and Zhu, 2010)
Matrix degrading enzyme
MMP13 NF-κB
p38
ERK
JNK
Human 
Bovine
Human
Bovine
(Pichika et al., 2005)
(Seguin et al., 2006)
(Xia and Zhu, 2010)
(Seguin et al., 2006) 
Matrix degrading enzyme
MMP14 ERK Bovine (Seguin et al., 2006) Matrix degrading enzyme
SOX-9 ERK Bovine (Kim et al., 2012) Transcription factor
TGF-1 p38 Rabbit (Studer et al., 2008) Growth factor
TIMP-1 p38
ERK
Rabbit
Bovine
(Studer et al., 2008)
(Kim et al., 2012)
Inhibitor of MMPs
TIMP-2 p38
ERK
Rabbit
Bovine
Bovine
(Studer et al., 2008)
(Kim et al., 2012)
(Kim et al., 2012)
Inhibitor of MMPs
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proteosomal degradation (Bubici et al., 2006; Hacker and 
Karin, 2006; Hayden and Ghosh, 2008; Karin and Ben-
Neriah, 2000; Ramana et al., 2004). IκB degradation allows 
NF-κB to translocate to the nucleus where it selectively 
binds to its cognate DNA consensus sequence, as well as 
co-activators such as Creb-binding protein (CPB)/p300, to 
induce gene expression (Furia et al., 2002). Stress-induced 
activation of NF-B leads to secretion of infl ammatory 
cytokines, increased expression of genes that regulate cell 
survival and growth, such as arrested proliferation or cell 
death, depending on the nature of the insult and extent of 
damage (Karin and Lin, 2002).
 As NF-κB also activates expression of IκB itself, NF-
κB activation is normally transient due to this negative 
feedback mechanism, lasting approximately 30-60 min in 
most cell types (Ghosh et al., 1998). However, this is only 
true for normal cells, whereas constitutive NF-κB activa-
tion could be observed in tumour cells (Sethi et al., 2008). 
Additionally, NF-κB regulation also takes place in the nu-
cleus via acetylation or phosphorylation, which modulate 
its transcriptional activity (Ghosh and Karin, 2002). More 
than 150 genes are regulated by NF-κB, including several 
proinfl ammatory mediators such as TNF-α, IL-1β, IL-6, 
cyclooxygenase-2 (COX-2), MMPs and adhesion mol-
ecules (Barnes and Karin, 1997; May and Ghosh, 1998).
Role of Chronic Activation of NF-B in Diseases
NF-κB is activated in response to numerous types of stress, 
including oxidative (Bubici et al., 2006), genotoxic (Wu 
et al., 2006), physical (Chen et al., 2001) and infl amma-
tory stress (Web ref. 2), that have been implicated in the 
pathogenesis of many diseases.  Indeed, chronic activation 
of NF-κB is associated with numerous diseases, including 
musculo-skeletal diseases such as osteoarthritis (Beren-
baum, 2004; Marcu et al., 2010), osteoporosis (Kim et al., 
2006), rheumatoid arthritis (Dai et al., 2004), and muscular 
dystrophy (Acharyya et al., 2007). For instance, expres-
sion of MMP1, MMP3, and MMP13 in chondrocytes is 
mediated primarily by activated NF-κB (Elliott et al., 2002; 
Liacini et al., 2003; Mengshol et al., 2000). In addition, 
activation of the NF-κB pathway is required for IL-1 to 
inhibit the expression of SOX-9, a transcription factor 
involved in chondrocyte differentiation (Murakami et al., 
2000). NF-κB signalling is found to be persistently elevated 
in immune cells and regenerative muscle fi bres of patients 
with Duchenne muscular dystrophy, the disorder associated 
with dystrophin defi ciency that results in chronic infl am-
mation and severe skeletal muscle degeneration (Acharyya 
et al., 2007). Oxidative stress-induced osteoclastogenesis 
in osteoporosis is also mediated by NF-κB signalling 
(Altindag et al., 2008).
 Overexpression of either the c-rel or p65/RelA subunit 
of NF-κB induces hallmark features of cellular senescence 
including decreased proliferation and morphologic chang-
es, such as enlarged, multinucleated cells (Bernard et al., 
2004; Bernard et al., 2001; Seitz et al., 2000). Moreover, 
NF-κB is up-regulated in tissues of aged rodents, specifi -
cally in the skin, liver, kidney, cerebellum, cardiac muscle 
and gastric mucosa (Bregegere et al., 2006; Giardina 
and Hubbard, 2002; Helenius et al., 1996a; Helenius et 
al., 1996b; Korhonen et al., 1997; Xiao and Majumdar, 
2000). Cells derived from elderly persons and patients with 
Hutchinson-Gilford progeria, a disease of dramatically 
accelerated aging, also exhibited increased NF-κB signal-
ling (Adler et al., 2007; Boland, 2001; Kriete et al., 2008). 
Growing evidence indicates that NF-κB becomes activated 
in aged tissues in response to accumulated damage and 
mediates the degenerative changes.  Indeed, a recent mod-
elling study identifi ed NF-κB as the transcription factor 
most associated with mammalian aging, and demonstrated 
that expression of a subset of NF-κB effectors is increased 
with aging (Adler et al., 2007). The role of NF-κB in aging 
is supported by the fact that genetic inhibition of NF-κB 
in skin reversed histological features of aging and signs 
of cellular senescence (Adler et al., 2007).
Current Knowledge on the Role of NF-B in the IVD
Role of NF-B in IDD
While NF-κB is implicated in a large number of diseases, 
only limited information of its role in IDD has been gen-
erated so far. Compared to asymptomatic autopsy disc 
samples, symptomatic (surgical) discs are characterised 
by increased levels of pro-infl ammatory cytokines that are 
considered typical NF-κB target genes, e.g. TNF-α, IL-1β, 
IL-6 and IL-8 (Adams et al., 2010; Bachmeier et al., 2007; 
Burke et al., 2002; Hoyland et al., 2008; Le Maitre et al., 
2005; Le Maitre et al., 2007; Ulrich et al., 2007). It is 
therefore likely that NF-κB activation is involved in disc 
disease. In fact, evidence supporting the role of NF-B in 
the IVD has been generated by immunohistochemical stud-
ies, demonstrating that activation of the NF-B signalling 
system occurs in the human IVD in vivo, especially in the 
nucleus pulposus tissue (Nerlich et al., 2007). Furthermore, 
NF-B activity in the IVD was shown to correlate with 
accumulated oxidative stress and increase with age and 
degeneration (Nerlich et al., 2007). Using a rabbit annular 
puncture model, intra-discal injection of ‘naked’ NF-B 
decoy oligonucleotides (ODN) proved effective in partially 
restoring IVD height, indicating that activation of NF-B 
is involved in matrix loss in this animal model of IDD 
(Akeda et al., 2005). Hence, NF-B most likely plays an 
important mediatory role in the disc degenerative process. 
However, further investigation is needed to confi rm if NF-
B is also involved in the development of a painful disc, 
as increased NF-B activity is found in both symptomatic 
and non-symptomatic degenerative discs.
Target genes
Although more than 150 NF-B-responsive genes have 
been identifi ed in multiple cell types (Barnes and Karin, 
1997; May and Ghosh, 1998), little is known about the gene 
targets of NF-B in the IVD (Table 1). MMP1, MMP2, 
MMP3, MMP9 and MMP13 have been identifi ed as NF-B 
target genes in IVD cells, as their protein levels are reduced 
by transfection of naked decoy oligonucleotides (ODN) 
into human IVD cells (Pichika et al., 2005). Furthermore, 
ADAMTS4 and ADAMTS5, the two major aggrecanases in 
the IVD, were most recently shown to be NF-κB dependent 
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(Wang et al., 2012). NF-B inhibition study in mouse disc 
tissue stimulated with recombinant TNF-α in the presence 
or absence of  chemical NF-B inhibitors also identifi ed 
vascular endothelial growth factor (VEGF) as a NF-B-
dependent disc gene (Ohba et al., 2009). The same group 
demonstrated that mRNA and protein expression of thymic 
stromal lymphopoietin (TSLP), which belongs to the 
cytokine family, is also regulated by the NF-B pathway 
in mouse IVD cells (Ohba et al., 2008). Furthermore, 
expression of monocyte chemoattractant protein-1 (MCP-
1), a chemotactic chemokine for macrophages, was shown 
to be regulated by the NF-B pathway in mouse IVD cells 
(Wako et al., 2008).
Activation
Different exogenous and endogenous stimuli can activate 
NF-κB in the IVD (Table 2). Stimulation of human disc 
cells with recombinant IL-1β caused nuclear translocation 
of p65 into the nucleus, as confi rmed by immunoblotting 
and immunocytochemistry as well as by electrophoretic 
mobility shift analysis (EMSA) (Wuertz et al., 2011). 
Stimulation of human IVD cells with IL-1 also resulted 
in activation of NF-κB (detected by EMSA), even after 3 
days (Yu et al., 2009). Similarly, TNF-α can also induce 
nuclear translocation of NF-κB in human IVD cells (Oh 
et al., 2010; Wang et al., 2012), but our own data indicate 
that this effect is less persistent compared to IL-1β (Fig. 
2). TNF-α-induced activation of NF-κB was also shown in 
murine disc tissue (Ohba et al., 2009). Similarly, tumour 
necrosis factor-like weak inducer of apoptosis (TWEAK) 
was also shown to induce NF-κB activation in mouse IVD 
tissue (Wako et al., 2008). In contrast, LPS treatment did 
not (or only very slightly) cause nuclear translocation of 
p65 in human IVD cells (Fig. 2), even though this has been 
described for p65 in the literature for other cell and tissue 
types (Crisostomo et al., 2008; Deshpande et al., 1997; 
Rodrigues et al., 2008).
 Furthermore, it was shown that peroxynitrite, one of 
the most damaging reactive oxygen species, was able to 
induce mRNA levels of IL-1β, IL-6 and IL-8 in human IVD 
cells and this was correlated with sustained nuclear trans-
location of p65. However, as no inhibition experiments 
or knockdown experiments were performed, the causal 
relationship between the peroxynitrite-induced NF-B 
activation and the alterations of these mRNAs can only 
be assumed (Poveda et al., 2009). Depending on the type 
and magnitude of loading, mechanical signals have been 
shown to either activate or inhibit the NF-κB pathway in 
Table 2: Summary of NF-κB and MAPK activators in IVD cells
Signalling Pathway Activator Species Reference
NF-κB IL-1 
IL-1β
Peroxynitrite
TNF-α 
TNF-α 
TWEAK
Human
Human
Human
Human
Murine
Mouse
(Yu et al., 2009)
(Wuertz et al., 2011) 
(Poveda et al., 2009)
(Oh et al., 2010)
(Wang et al., 2012)
(Ohba et al., 2009)
(Wako et al., 2008)
p38 IL-1β
Lactoferricin
Osmolality ↑ 
Oxygen 
TGF-1
TNF-α 
Human
Bovine
Bovine
Rat
Bovine
Bovine
(Wuertz et al., 2011) 
(Kim et al., 2012)
(Mavrogonatou and Kletsas, 2009)
(Risbud et al., 2005b)
(Tsai et al., 2007b)
(Seguin et al., 2006)
ERK bFGF
Fibronectin frag.
IGF-I
IL-1β
Lactoferricin
NGF
Osmolality
Osmolarity ↑
Oxygen 
PDGF
TGF-1
TGF-3
TNF-α
Bovine
Human
Bovine
Human
Bovine
Rat
Bovine
Rat
Rat
Bovine
Bovine
Rat
Bovine
(Pratsinis and Kletsas, 2007)
(Xia and Zhu, 2010)
(Pratsinis and Kletsas, 2007)
(Wuertz et al., 2011) 
(Kim et al., 2012)
(Uchiyama et al., 2007)
(Mavrogonatou and Kletsas, 2011)
(Tsai et al., 2007a)
(Risbud et al., 2005a; Risbud et al., 2005b)
(Pratsinis and Kletsas, 2007)
(Tsai et al., 2007b)
(Risbud et al., 2006)
(Seguin et al., 2006; Seguin et al., 2008)
JNK IL-1β
Osmolality
TNF-α
TWEAK
Human
Bovine
Bovine
Mouse
(Wuertz et al., 2011) 
(Mavrogonatou and Kletsas, 2011)
(Seguin et al., 2006)
(Wako et al., 2008)
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chondrocytes (Agarwal et al., 2003; Deschner et al., 2003). 
Similarly, hypoxia has been reported to enhance NF-κB 
activity (primarily through the canonical pathway) in low 
oxygen tissues, but no data is currently available with 
regard to the IVD (Oliver et al., 2009).
Inhibition/Therapy
Suppression of NF-κB has become a major research target 
to treat diseases in the past years. Different strategies to 
block NF-κB have been investigated, such as the use of 
proteasome inhibitors, which may inhibit degradation of 
IκB upon phosphorylation and ubiquitination (Ahn et al., 
2007; Palombella et al., 1994). Other possibilities may be 
to block IKK, the upstream regulator that phosphorylates 
IκB (Ji et al., 2001), or to modify IκB at the phosporyla-
tion or ubiquitination sites via gene transfer (Abu-Amer et 
al., 2001). In addition, a large group of anti-infl ammatory 
drugs seem to have the potential to inhibit NF-κB. On the 
one hand, there are several traditional drugs that have been 
commonly used for decades, such as acetylsalicylic acid, 
ibuprofen or glucocorticoids, e.g. dexamethasone, which 
have NF-κB inhibitory activities (Auphan et al., 1995; 
Kopp and Ghosh, 1994). Furthermore, more “modern” 
pharmaceuticals, such as the COX-2 inhibitor rofecoxib, 
can infl uence NF-B activity, e.g. in this case by inhibit-
ing its DNA binding capacity (Niederberger et al., 2003). 
On the other hand, there are multiple “natural” candidates 
that seem to inhibit NF-κB in certain cell types, such as 
resveratrol (a polyphenol found in wine) (Holmes-McNary 
and Baldwin, 2000), curcumin (the main component of 
curcuma) (Jobin et al., 1999; Surh et al., 2000) or capsaicin 
(found in red pepper) (Surh et al., 2000).
 In human IVD cells, the well known anti-infl ammatory 
steroid drug dexamethasone, which has been described to 
act as an inhibitor of NF-B, was not able to inhibit the 
transcription of NF-B stimulated by TNF-α in human IVD 
Fig. 2. Time-dependent activation of NF-κB in human IVD cells after stimulation with TNF-α (10 ng/mL), IL-1β (5 
ng/mL) or LPS (1 μg/mL) was tested by (A) immunocytochemistry for p65 (after 10, 30, 60, 120, 180 and 240 min) 
and (B) immunoblotting for p65 in nuclear extracts (30 min: left side, 60 min: right side). For detection of p65, a 
specifi c NF-κB/p65 antibody from Santa Cruz was used (sc-372). White arrows indicate nuclear translocation and 
yellow arrows indicate cytoplasmic location. Negative controls for immunocytochemistry were exposed to the second-
ary antibody (CY2), but not to the primary p65 antibody. PARP was used as a loading control for immunoblotting.
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cells, as shown by the EMSA experiments (Oh et al., 2010). 
Similarly, the polyphenol resveratrol did not reverse IL-1β 
induced activation of NF-κB as demonstrated by EMSA, 
immunoblotting and immunocytochemistry (Wuertz et al., 
2011), although this has been described for chondrocytes 
(Shakibaei et al., 2008). Furthermore, the effect of resvera-
trol on insulin resistance and infl ammatory mediators in 
obese and type 2 diabetic subjects is being investigated in 
a clinical trial (see http://clinicaltrials.gov).
 Curcumin, a potential biological NF-B inhibitor, did 
not inhibit IL-1β-induced activity of nuclear translocation 
of p65 at an early time point as shown in Fig. 3 (results not 
yet published), while late IL-1-induced activity of NF-B 
(after 3 days) was reduced when treated with curcumin (Yu 
et al., 2009). As NF-B is continuously shuttling between 
the nucleus and cytoplasm, assays measuring NF-B acti-
vation by nuclear translocation (i.e. presence of p65 in the 
nucleus) can give variable results if the dose of inhibitor 
or time point of analysis are not optimally determined. It 
is also possible that the mechanisms of NF-B activation 
and inhibition in disc cells are different from those found in 
other cell types. Hence, although time course experiments 
have been performed in most of the above-mentioned stud-
ies, a negative result cannot completely rule out inhibition 
of NF-B by the tested substances. Nevertheless, the failure 
of NF-B inhibition using well-established pharmaceuti-
cals (e.g. dexamethasone) or natural substances at least 
challenges the effi cacy of this therapeutic approach.
 Aside from NF-B inhibition with “traditional sub-
stances” (as described above), another strategy that targets 
NF-B has been investigated recently: NF-B decoy 
transduction into dorsal root ganglion neurons in vivo has 
been tested in a rat lumbar disc herniation model with 
regard to its effi cacy in altering nerve injury, mechanical 
allodynia and thermal hyperalgesia. This strategy reduced 
nerve injury, improved mechanical allodynia and thermal 
hyperalgesia in this animal model (Suzuki et al., 2009) 
and may thus be a promising new approach but one that 
will require more detailed investigations in the future. A 
recent study revealed that systemic inhibition of NF-κB 
activation by the inducible IKK via chronic administration 
of the Nemo Binding Domain peptide inhibitor, 8K-NBD, 
in a mouse model of progeria (Ercc1-/∆ mice) delayed the 
onset of  age-related IDD (Fig. 4) (Nasto et al., 2011). For 
adults with mild to moderate atopic dermatitis, the use of 
NF-B Decoy is being currently investigated in clinical 
trials (http://clinicaltrials.gov).
MAPK Signalling Pathways
MAPKs are a family of highly conserved signal transduc-
tion pathways, allowing the cells to respond to multiple 
extracellular inputs. MAPKs are activated by different 
stimuli, such as hormones and growth factors acting 
through tyrosine or serine/threonine kinases, infl amma-
tory cytokines, peptides acting through G protein-coupled 
receptors, as well as environmental stresses such as ionising 
radiation or osmotic stress (Huang et al., 2010; Kyriakis 
and Avruch, 2001). In mammals, these diverse signals 
activate at least three major subfamilies of MAPKs, the 
extracellular signal-regulated kinases (ERK), c-Jun NH2-
terminal kinases (JNKs), and p38 isoforms (p38MAPKs) 
(Boutros et al., 2008; Wagner and Nebreda, 2009). All 
MAPKs are activated following a common cascading pat-
Fig. 3. Analysis on NF-B (p65) and JNK activity after stimulation of human IVD cells with curcumin. Human 
IVD cells were treated with IL-1 to induce activation of (A) NF-B (nuclear translocation of p65) and (B) 
JNK (phosphorylation) and co-treated with 20 M curcumin. Nuclear extracts (for NF-B/p65) or whole cell 
extracts (for JNK) were harvested after 30 min and 60 min, respectively, and analysed by immunoblotting. While 
curcumin did not reduce nuclear translocation of p65 (compared to IL-1-treated samples), it was able to reduce 
phosphorylation of JNK (compared to IL-1-treated samples). Results for p65 and JNK of one representative 
donor are shown. Loading controls: PARP for p65, tubulin for JNK.
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tern, i.e. each member of the family of MAPK is activated 
by specifi c upstream kinases (MAPKK) through phospho-
rylation on threonine and tyrosine residues, while each 
MAPKK is activated by a MAPKK kinase (MAPKKK) 
by phosphorylation on serine or threonine residues (Imajo 
et al., 2006).
 ERK 1/2 was the fi rst mammalian MAPK pathway 
to be identifi ed. It is regulated by the activation of the 
GTPase Ras, which recruits MAPKKKs of the Raf family 
and activate the MEK1 and MEK2 MAPKKs, which in 
turn activate the ERKs by phosphorylation (Chambard et 
al., 2007; Kyriakis and Avruch, 2001). Activation of the 
ERK pathway was found to control several cellular func-
tions, including cell cycle progression. This is achieved by 
ERK-mediated regulation of components of the cell cycle 
machinery, such as c-Myc, cyclin D1 and cyclin-dependent 
kinases that phosphorylate the retinoblastoma protein, lead-
ing to the release of the E2F transcription factors and thus 
allowing the transition from the G1 to the S phase of the 
cell cycle (Chambard et al., 2007). JNKs are activated by 
various exogenous stresses, which lead to phosphorylation 
of tyrosine and threonine residues by the upstream kinases 
MMK4 and MKK7. JNKs are involved in the regulation of 
cell proliferation and survival (Wagner and Nebreda, 2009). 
Finally, the p38 MAPK pathway is also activated by many 
diverse stresses, resulting in dual phosphorylation on its 
threonine and tyrosine residues by the upstream kinases 
MKK3/6. Activation of p38 MAPK is associated with cell 
growth and differentiation, cell death and infl ammation 
(Kaminska, 2005; Kyriakis and Avruch, 2001; Pearson 
et al., 2001). There are four known isoforms expressed 
in mammalian cells, i.e. p38α, p38β, p38γ and p38δ, and 
the fi rst two are expressed in most tissues, while p38γ and 
p38δ are exclusively found in muscle, skin and kidney 
cells (Han and Sun, 2007; Huang et al., 2010). Amongst 
the various stimuli activating p38 are infl ammatory cy-
tokines (e.g. interleukins and TNF-α), pathogenic stimuli 
(such as LPS, staphylococcal peptidoglycan, enterotoxin 
B and herpes simplex virus I) (Kaminska, 2005), and UV 
and gamma radiation (Dent et al., 2003). A summary of 
the known MAPK cascades, including ERK5, which has 
not been investigated in the disc so far, is given in Fig. 1.
Roles of MAPKs in Diseases
As MAPKs are activated by several exogenous stimuli 
commonly found in infl ammatory diseases, e.g. infl amma-
tory cytokines and growth factors, pathogenic components, 
reactive oxygen species, etc., these signalling pathways are 
closely involved in diseases such as rheumatoid arthritis, 
psoriasis, infl ammatory bowel disease, neurodegenera-
tive diseases or cancer (Huang et al., 2010; Wagner and 
Nebreda, 2009; Zarubin and Han, 2005). Hence, MAPKs 
represent important targets for therapeutic interventions. 
In this context, several specifi c kinase inhibitors have been 
developed for the regulation of these pathways, with the 
aim to function as anti-infl ammatory agents. A few com-
pounds have been used in clinical trials. However, toxic 
side effects still represent a major obstacle (Huang et al., 
2010; Kaminska, 2005), probably due to the pivotal roles 
of the MAPK pathways in normal cellular physiology.
Fig. 4. Pharmacologic suppression of IKK/NF-κB activation ameliorates age-associated disc proteoglycan loss. 
Ercc1-/∆ mice were treated with 10 mg NBD per kg body weight three times per week intraperitoneally start-
ing from 5 weeks of age until 20 weeks of age. Safranin O histological staining of disc sections of NBD-treated 
Ercc1-/∆ mice and untreated Ercc1-/∆ mice. Endplate (EP), nucleus pulposus (NP), and annulus fi brosus (AF) are 
indicated. Red, Safranin O staining of proteoglycan. NBD treatment increased Safranin staining of NP of Ercc1-/∆ 
mice compared to untreated mice.
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 Cellular senescence, which is increased in aged and 
degenerated discs, is regulated by the MAPK pathways 
(Gruber et al., 2010; Gruber et al., 2007; Kletsas, 2009; 
Roberts et al., 2006). In several cell types, activation of 
p38 MAPK, for example, is used as a marker of senescence 
(Chen and Ames, 1994; Iwasa et al., 2003; Papadopoulou 
and Kletsas, 2011), while constitutive activation of p38 
via MKK3 or MKK6 is reported to induce premature se-
nescence via the upregulation of cyclin-dependent kinase 
inhibitors (Wang et al., 2002; Wu, 2004). In addition, the 
MEK/ERK pathway is involved in the oncogenic Ras 
induced senescence (Lee et al., 1999; Maruyama et al., 
2009), while JNK has been reported to inhibit or provoke 
cellular senescence under different settings (Maruyama et 
al., 2009).
Current Knowledge on the Role of MAPKs
in the IVD
Role of MAPKs in IDD
MAP kinases have received greater attention in the IVD 
research community during the past few years. However, 
little information still exists on their expression and activity 
in relation to the progression of IDD. With laser capture 
microdissection (LCM) microarray, which can be used to 
identify cell-specifi c gene expression patterns, Gruber et al. 
(2010) provided evidence that p38 MAPK gene expression 
is upregulated in senescent human AF cells compared to 
non-senescent cells. Furthermore, in a rodent in vivo stab 
injury model, annular fi broblasts became immunopositive 
for the phosphorylated form of p38 and produced increased 
levels of proinfl ammatory factors, such as IL-1 and TNF- 
(Ulrich et al., 2007).
 The MAPK signalling pathways seem to play a crucial 
role in modulating both matrix synthesis and degradation 
in the IVD by altering expression of anabolic and catabolic 
genes, as well as by infl uencing proteoglycan degradation 
in the IVD.  In particular, the p38 and ERK signalling 
pathways have been shown to play a role in proteoglycan 
metabolism, as treatment with chemical inhibitors of p38 
or ERK signifi cantly counteracted the cytokine-induced 
decrease in proteoglycan content, synthesis and release 
(Seguin et al., 2006; Studer et al., 2008). For the fi rst time, 
ERK is recently reported to be involved in the activation 
of Wnt/b-catenin signals, which may contribute to the 
pathogenesis of IDD (Hiyama et al., 2011). Furthermore, 
activation of p38 by hyperosmotic conditions (as seen in 
the IVD during daily activity) has an inhibitory effect on 
cell proliferation via induction of a G2 arrest in bovine NP 
cells (Mavrogonatou and Kletsas, 2009). On the other hand, 
ERK activation plays an important role in cell adhesion 
by positively infl uencing 2-integrin expression, as well 
as cell adhesion to collagen II substrates in rat NP cells 
(Risbud et al., 2005b). In addition, activation of ERK and 
p38, which was shown to be higher in freshly isolated com-
pared to expanded bovine IVD cells (Tsai et al., 2007b), 
can counteract apoptosis induced by mechanical stress (in 
the endplate (EP) and transitional zone of AF) (Ariga et al., 
2003) or by serum starvation under hypoxic conditions (in 
the rat NP) (Risbud et al., 2005a). As mentioned above, 
several growth factors exert their mitogenic action by acti-
vating ERK by phosphorylation. On the other hand, several 
growth factors and growth factor receptors have been found 
to be over expressed in degenerated discs (Pratsinis and 
Kletsas, 2008). Likewise, classical growth factors such as 
platelet-derived growth factor (PDGF), insulin-like growth 
factor-I (IGF-I) or basic fi broblast growth factor (bFGF), 
which are known to be overexpressed in degenerated disc 
tissue, can stimulate ERK and subsequent DNA synthesis 
in bovine AF and NP cells in vitro (Pratsinis and Kletsas, 
2007), indicating that MAPKs are possibly involved in 
catabolic and anabolic processes in the IVD.
Target genes
MMP9, MMP13, MMP14, inducible nitric oxide synthase 
(iNOS), tissue inhibitor of metalloproteinases (TIMP)-1, 
TIMP-2, TIMP-3, aggrecan, collagen II, SOX-9, acid-
sensing ion channel (ASIC)3 and tonicity-responsive en-
hancer binding protein (TonEBP) all have been identifi ed 
as target genes of ERK in IVD cells of various species 
(Kim et al., 2012; Seguin et al., 2006; Tsai et al., 2007a; 
Uchiyama et al., 2007; Xia and Zhu, 2010). Furthermore, 
the ERK pathway seems essential in regulating the enzy-
matic activation of MMP2 via early growth factor EG-1 
(Seguin et al., 2008). The p38 pathway controls expression 
of MMP1, MMP3, MMP13, IL-6, IL-8, COX-2, iNOS, 
VEGF, IGF-1, transforming growth factor (TGF)- and 
TonEBP (Kim et al., 2009; Kim et al., 2012; Seguin et al., 
2006; Studer et al., 2008; Tsai et al., 2007a) and infl uences 
levels of prostaglandin (PGE)2, PGF2 and nitrite (Kim et 
al., 2009; Studer et al., 2008). Furthermore, expression of 
the anabolic and anti-catabolic genes aggrecan, collagen I, 
collagen II, versican, TIMP-1, TIMP-2 and TIMP-3 seems 
to be infl uenced by the p38 MAPK pathway as well (Kim 
et al., 2012; Studer et al., 2008). Finally, JNK was shown 
to regulate expression of MMP1, MMP3 and MMP13 
(Seguin et al., 2006; Wako et al., 2008).  All genes known 
to be regulated by MAPKs in disc cells are summarised 
in Table 1.
Activation
Several signalling molecules of MAPK pathways in IVD 
cells have been identifi ed in the past years (Table 2). The 
proinfl ammatory cytokines TNF- and IL-1are able to 
induce activation of the ERK, p38 and JNK pathways 
in bovine, rabbit and human IVD cells (Klawitter et al., 
2011; Seguin et al., 2006; Seguin et al., 2008; Studer 
et al., 2008; Wuertz et al., 2011). Treatment of rat IVD 
cells with nerve growth factor (NGF) resulted in a rapid 
increase in the levels of phosphorylated ERK, which was 
mediated through the low-affi nity neurotrophin receptor 
(p75NTR) (Uchiyama et al., 2007). Furthermore, the 
fragmented form of the matrix protein fi bronectin was 
shown to induce phosphorylation of ERK1/2 in a protein 
kinase C (PKC)-dependent manner (Xia and Zhu, 2010). 
Lactoferricin, a glycoprotein from the transferrin family, 
was also shown to activate the p38 and ERK signalling 
in bovine NP cells (Kim et al., 2011) and TGF--induced 
levels of phosphorylated ERK1/2 and p38 (Risbud et al., 
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2006; Tsai et al., 2007b). JNK activation was shown to take 
place upon stimulation of mouse IVD tissue with TWEAK 
(Wako et al., 2008).
 Other environmental factors also seem to play a crucial 
role in MAPK activation: hyperbaric oxygen for example 
reduced phosphorylation of p38 MAPK in human IVD 
cells (Niu et al., 2011). High osmolarity, to which NP 
cells are exposed during daily activities (Urban, 2002), 
resulted in p38 MAPK activation in bovine NP cells, 
while the activation of ERK and JNK was inhibited 
under these conditions (Mavrogonatou and Kletsas, 
2009; Mavrogonatou and Kletsas, 2010; Mavrogonatou 
and Kletsas, 2011). Notably, this differential regulation 
of MAP kinases was observed after stimulation of cells 
with a salt solution (NaCl/KCl) or the osmolyte sorbitol 
but not by urea, indicating that these effects are due to 
changes in osmolality and not to increased ionic strength 
(Mavrogonatou and Kletsas, 2011). It is well known that 
one of the characteristics of the disc NP cells’ environment 
is high osmolality due to the abundance of proteoglycans. 
This osmolality can increase further during daily activities, 
but it is decreased in the degenerated discs. These changes 
affect also growth factor-mediated ERK activation. In 
particular, while ERK activation is decreased under 
hyperosmotic conditions in bovine NP cells, its activation 
is enhanced in hypoosmotic conditions, indicating that the 
conditions of the degenerated disc are more permissive for 
cell proliferation and repair (Mavrogonatou and Kletsas, 
2010). In contrast, in rat NP cells, hyperosmotic culture 
conditions induced by NaCl supplementation of the medium 
were shown to increase phosphorylation and activation of 
ERK (Tsai et al., 2007a). Furthermore, hypoxic conditions 
induced phosphorylation of both, p38 and ERK MAPK in 
rat NP cells (Risbud et al., 2005a; Risbud et al., 2005b). 
Cellular responses to microenvironmental factors, i.e. 
alteration in oxygen levels and osmotic pressure, are 
inherent mediatory steps in the degenerative processes 
of the IVD. Activation of MAPK signalling pathways by 
exogenous stresses seems to affect several aspects of IVD 
homeostasis. Hypoxic environment activates ERK leading 
to the upregulation of α2 integrin and to an increased cell 
survival in discs (Risbud et al., 2005b). In addition, hypoxia 
increases the expression of β-1,3-glucuronyltransferase 1 
(GlucAT-1), a key enzyme in glucosaminoglycan synthesis, 
a process that is partly mediated by ERK activation (Gogate 
et al., 2011). Furthermore, hypertonicity activates ERK 
in rat NP cells, leading to the transactivation of TonEBP, 
a transcription factor that is involved in the adaptation to 
osmotic stress and in the regulation of aggrecan expression 
(Tsai et al., 2007a). This is in agreement with the effect of 
osmotic stress on aggrecan overexpression in chondrocytes 
(Peffers et al., 2010). Finally, exposure of disc cells to 
high osmolality decreased the phosphorylation of ERK in 
response to serum or to isolated growth factors, such as 
PDGF or IGF-I, thus inhibiting bovine NP cell proliferation 
(Mavrogonatou and Kletsas, 2010; Pratsinis and Kletsas, 
2007).
Inhibition/Therapy
Inhibition of MAPK activity under infl ammatory stress-
ful conditions has been demonstrated to be potentially 
benefi cial in treating IDD by stimulating matrix protein 
expression (aggrecan, collagen-I, collagen-II, versican) 
and by inhibiting expression of infl ammatory mediators 
(IL-1, IL-6, COX-2, NO, PGE-2) and matrix degrading 
enzymes (MMP3) (Niu et al., 2011; Studer et al., 2008). 
So far, several chemical/biological therapeutics as well as 
external factors have been identifi ed that can infl uence the 
activity of the specifi c MAPKs. While no clinical studies 
have been performed so far with regard to IDD, several 
MAPK inhibitors, especially p38 MAPK inhibitors, are 
currently being investigated for other infl ammation-related 
diseases. For rheumatoid arthritis, the effi cacy and safety 
of oral medication of the p38 MAP kinase inhibitors VX-
702, RO4402257 or PH-797804 are being determined in 
ongoing clinical studies (http://clinicaltrials.gov).
 Phosphorylation (and thus activation) of p38 can be 
reduced by link N peptide (the N-terminal peptide of link 
protein) (Petit et al., 2011) and triptolide (diterpenoid 
triepoxide form the Chinese herb, Tripterygium wilfordii 
Hook) (results not yet published) in human IVD cells, with 
an overall pro-anabolic, anti-catabolic and anti-infl am-
matory effect. Furthermore, triptolide also inhibited ERK 
activation, while curcumin (the principal curcuminoid in 
curcuma/tumeric) reduced activation of JNK in human disc 
cells (Fig. 3) (Klawitter et al., 2011). Application of the p38 
chemical inhibitor SB202190 in human AF cells co-cul-
tured with macrophages or stimulated with TNF- caused 
a signifi cant reduction in proinfl ammatory cytokines and 
prostaglandins, indicating that p38 blockage may be useful 
for the treatment of IDD (Kim et al., 2009). The anabolic, 
anti-catabolic and anti-infl ammatory response of IVD cells 
treated with the p38 inhibitor SB202190 was confi rmed in 
rabbit IVD cells exposed to infl ammatory signals (Studer et 
al., 2008). On the other hand, the glycoprotein lactoferricin 
caused anabolic effects in bovine NP cells via activation 
of p38 and ERK, and this effect was reversed by treatment 
with the p38 inhibitor SB203580 or the ERK inhibitor 
PD98059 (Kim et al., 2011).
 Importantly, multiple studies in the last decade suggest 
that MAPK inhibitors may also offer therapeutic potential 
for patients with sciatic nerve crush, spinal nerve ligation 
or disc herniation. In fact, MAP kinase activity has been 
shown to be elevated in conditions mentioned above (Doya 
et al., 2005; Ito et al., 2007; Jin et al., 2003; Kominato et 
al., 2003; Myers et al., 2003; Obata et al., 2004; Schafers et 
al., 2003; Zhuang et al., 2005; Zhuang et al., 2006). In light 
of this, asialo-erythropoietin, a nonerythropoietic cytokine, 
was recently shown to reduce levels of phosphorylated 
p38 and improve pain-related behaviour (as measured by 
von Frey fi lament testing) in a rat model of lumbar disc 
herniation  (Sasaki et al., 2010). Furthermore, MAPK 
inhibitors seem to have the ability to reduce neuropathic 
pain. These include the use of JNK peptide inhibitor D-
JNKI-1 in a model of spinal nerve ligation (Zhuang et al., 
2006), p38 inhibitor SB203580 in a model of spinal nerve 
ligation (Schafers et al., 2003) and p38 inhibitor SD-169 
in a model of sciatic nerve crush (Myers et al., 2003).
 However, despite the promising potential of MAPK 
inhibitors, their risk-benefi t ratio remains controversial. 
This is because inhibition of MAPKs, which are involved 
in a multitude of physiological processes, may lead to 
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detrimental side effects. Inhibition of the ERK-mediated 
pathway (regulator of growth factor signalling) and JNK-
mediated pathway (modulator of cell proliferation, differ-
entiation and apoptosis) may cause general cytotoxicity. 
For instance, inhibition of the p38 MAPK pathway blocks 
chondrocyte differentiation (Jin et al., 2006; Li et al., 2010; 
Li et al., 2009). A careful screening will thus have to be 
done using MAPK inhibitors to treat IDD in order to rule 
out a potential anti-anabolic or toxic behaviour.
Summary
Based on existing information, NF-κB and MAP kinases 
appear to be potentially ideal therapeutic targets to treat 
IDD. P38 MAPK inhibition, either via natural compounds 
(e.g. curcumin, triptolide) or synthetic compounds (e.g. 
SB202190, PD38059, SB203580), was shown to reduce 
infl ammatory and catabolic responses in intervertebral 
disc cells and ameliorate stress-induced loss of matrix 
anabolism. Reduction of NF-κB, either via genetic or 
pharmacologic intervention, also mitigates age-associated 
disc matrix proteoglycan loss. However, because these 
signalling pathways regulate a large number of genes in 
cellular response to a variety of stressors, general non-
discriminating inhibition of these pathways may produce 
unanticipated deleterious side effects, such as general 
toxicity, cell proliferation, or inhibition of anabolism and 
differentiation. Therefore, much more basic research is 
needed to gain a better understanding of these complex 
pathways and how their interactions determine the outcome 
of IDD treatment through inhibiting these pathways. In 
fact, we are only beginning to explore the pathways that 
regulate intervertebral disc homeostasis, degeneration 
and infl ammation. A number of important questions still 
remain unanswered. It is still unclear whether NF-κB or 
MAPK activation levels correspond to the different stages 
of IDD, which physiologic stressors trigger their activa-
tion, and how disc matrix homeostasis is affected as the 
result of such activation. Future research will also have to 
address the distinct roles of specifi c MAPK isoforms, as 
well as the complex interplay of the reviewed signalling 
pathways. These and other insights will be crucial for 
identifying specifi c therapeutic molecular targets within 
these pathways in order to minimise the toxic side effects 
in the treatment of IDD through inhibiting these pathways.
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Discussion with Reviewers
Reviewer I: Would there ever be any use of inhibitors of in-
tracellular signalling pathways such as NFkB, in targeting 
disease, given their usually crucial role in other processes?
Authors: The authors believe that NF-κB and/or MAP 
kinases are potentially promising drug targets, at least for 
diseases which are characterised by aberrant activation of 
these pathways, e.g. certain types of cancer or infl ammatory 
diseases. Abnormal hyperactivation of these intracellular 
signalling pathways in diseased IVD tissue of patients 
with discogenic back pain needs to be confi rmed prior 
to contemplating the use of inhibitors of these pathways 
as therapeutic treatment. However, in order to minimise 
potential side effects that would almost certainly occur 
with systemic delivery, methods for targeted delivery (i.e. 
limiting the action to the desired tissue, in this case the 
IVD) are needed. Furthermore, effi cacy and safety need 
to be assessed and ascertained by tightly controlling the 
duration and magnitude of inhibition (e.g. by using an ap-
propriate regulated slow release system).
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Reviewer II: Many of the therapeutic agents targeted for 
inhibition of transcription factors have not been success-
ful in clinical trials, primarily due to their diverse effects 
in various cells and situations. Do the authors believe that 
these agents will benefi t patients with IVD disease? If 
so, what is the potential therapeutic targets and delivery 
methods?
Authors: As NF-B or MAP kinases play essential roles 
in infl ammatory responses, these signalling pathways 
may be relevant therapeutic targets. In fact, many drugs 
that have been used for decades have most recently been 
shown to interfere with these signalling pathways, e.g. 
glucocorticoids or acetylsalicylic acid. In addition, much 
research effort has been undertaken to develop novel NF-
B or MAPK inhibitors. However, a general inhibition of 
NF-B or MAPK signalling when treating infl ammation-
related diseases such as IDD could cause undesirable, 
detrimental side effects in many other tissues or organs. 
Disc tissue-specifi c delivery system might be necessary to 
control the respective signalling pathway within the IVD, 
while not affecting other tissues. Thus, IVD-specifi c ap-
plication of inhibitors, e.g. by intradiscal injection or via 
gene therapy approaches, may enable such a cell specifi c 
molecular intervention. Despite ongoing clinical trials that 
use either NF-B (e.g. by PS-1145, SPC-839 or SC-514) 
or p38 MAPK (SB-681323, RO4402257, PH-797804) in-
hibitors for various diseases, such as atopic dermatitis and 
rheumatoid arthritis, many fundamental aspects will need 
to be evaluated both in in vitro studies and in appropriate 
animal models before these approaches become realistic 
therapeutic options for IDD patients. Despite these chal-
lenges, the NF-B and MAPK signalling pathways remain 
the most relevant and promising therapeutic targets for 
infl ammation-related diseases such as IDD.
